HCI Emerging Growth

HCI Emerging Growth was a specialized investor relations and strategic communications firm that operated as a division of HC International. The firm focused on providing corporate positioning, financial public relations, and investor outreach services for emerging growth companies, with a significant emphasis on the healthcare, biotechnology, and life sciences sectors. It was particularly active in the mid-2000s, representing various U.S.-listed Chinese pharmaceutical companies and other healthcare entities during the peak of the reverse merger boom. The firm was led by partners such as Alan Sheinwald and has since been succeeded by Alliance Advisors.